Filing Details
- Accession Number:
- 0001618835-19-000214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-04 17:34:05
- Reporting Period:
- 2019-12-02
- Accepted Time:
- 2019-12-04 17:34:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1618835 | Evofem Biosciences Inc. | EVFM | Pharmaceutical Preparations (2834) | 208527075 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1726183 | Kelly Culwell | C/O Evofem Biosciences, Inc. 12400 High Bluff Drive, Suite 600 San Diego CA 92130 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-12-02 | 1,000 | $7.35 | 43,538 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 25, 2019.
Billionaire Hedge Funds
